header image

Virus & Prion Validation

The Virus & Prion Validation unit support Octapharma’s commitment to safe protein products derived from human plasma and human cell lines.

 

The state-of-the-art Frankfurt facility is certified to Good Laboratory Practice (GLP) for the provision of comprehensive GLP-compliant virus and prion validation studies with the highest level of quality and regulatory compliance.

 

Work includes:

 

  • Research and validation of virus and other pathogen inactivation steps in novel production processes 

  • Re-validation and robustness studies of established production process steps in a laboratory scale in the presence of viruses including HIV, HCV and WNV

  • Research on emerging new viruses